We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+13.53%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$621M
AUM Growth
+$20.1M
Cap. Flow
-$22.6M
Cap. Flow %
-3.65%
Top 10 Hldgs %
21.38%
Holding
378
New
64
Increased
44
Reduced
185
Closed
47

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.9M
2
LLY icon
Eli Lilly
LLY
+$8.6M
3
DVN icon
Devon Energy
DVN
+$6.91M
4
MSFT icon
Microsoft
MSFT
+$6.48M
5
AX icon
Axos Financial
AX
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 26.01%
2 Healthcare 16.33%
3 Energy 9.94%
4 Consumer Discretionary 9.36%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRDO icon
176
Perdoceo Education
PRDO
$1.97B
$910K 0.15%
134,022
-3,123
-2% -$21.2K
CAFD
177
DELISTED
8point3 Energy Partners LP
CAFD
$904K 0.15%
62,757
MITK icon
178
Mitek Systems
MITK
$837M
$900K 0.15%
108,610
-152,549
-58% -$1.2M
ITW icon
179
Illinois Tool Works
ITW
$82.3B
$899K 0.14%
7,500
IDTI
180
DELISTED
Integrated Device Technology I
IDTI
$893K 0.14%
38,659
-79,817
-67% -$1.65M
SUM
181
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$890K 0.14%
+50,059
New +$969K
SGRY icon
182
Surgery Partners
SGRY
$2B
$888K 0.14%
43,864
+21,036
+92% +$386K
ESV
183
DELISTED
Ensco Rowan plc
ESV
$888K 0.14%
26,107
OFIX icon
184
Orthofix Medical
OFIX
$418M
$882K 0.14%
+20,613
New +$920K
BMRN icon
185
BioMarin Pharmaceuticals
BMRN
$13.3B
$876K 0.14%
9,467
-5,944
-39% -$560K
WLDN icon
186
Willdan Group
WLDN
$1.27B
$850K 0.14%
48,405
-1,134
-2% -$16.3K
BCR
187
DELISTED
CR Bard Inc.
BCR
$843K 0.14%
3,757
NOVT icon
188
Novanta
NOVT
$6.34B
$841K 0.14%
48,467
-1,137
-2% -$18.7K
DSPG
189
DELISTED
DSP Group Inc
DSPG
$840K 0.14%
69,904
-1,627
-2% -$18.1K
TRMB icon
190
Trimble
TRMB
$12.9B
$839K 0.14%
29,374
RICE
191
DELISTED
Rice Energy Inc.
RICE
$828K 0.13%
31,703
+1,017
+3% +$25.2K
WAB icon
192
Wabtec
WAB
$49.8B
$827K 0.13%
10,132
-1,161
-10% -$85.2K
BMI icon
193
Badger Meter
BMI
$3.8B
$824K 0.13%
24,592
-21,344
-46% -$737K
CTLP
194
DELISTED
Cantaloupe
CTLP
$817K 0.13%
145,743
-3,414
-2% -$16.8K
POT
195
DELISTED
Potash Corp Of Saskatchewan
POT
$815K 0.13%
49,950
-194,674
-80% -$3.21M
EVDY
196
DELISTED
Everyday Health, Inc.
EVDY
$815K 0.13%
105,979
-2,666
-2% -$20.9K
PRIM icon
197
Primoris Services
PRIM
$4.32B
$813K 0.13%
39,487
-2,273
-5% -$42.9K
GENC icon
198
Gencor Industries
GENC
$259M
$804K 0.13%
67,127
-1,573
-2% -$18K
AXGN icon
199
Axogen
AXGN
$2.62B
$802K 0.13%
88,823
-41,459
-32% -$337K
CCRN
200
DELISTED
Cross Country Healthcare
CCRN
$793K 0.13%
67,304
-3,114
-4% -$41K

Similar funds

Essex Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Essex Investment Management held 378 positions worth $621M, up 3.4% from $601M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Essex Investment Management withdrew a net $22.6M in Q3 2016, closing 47 positions and reducing 185 holdings. Its most notable exit was Royal Gold, an estimated $4.45M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Essex Investment Management opened a new position in Devon Energy worth $7.51M.

  • Essex Investment Management's largest Q3 2016 buy was Devon Energy: 170,287 shares worth $7.51M.
  • Essex Investment Management added most to Apple in Q3 2016, an estimated $14.9M increase.
  • Essex Investment Management's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $13.9M.
  • Essex Investment Management fully exited Royal Gold in Q3 2016, selling an estimated $4.45M.
  • Essex Investment Management's ten largest holdings make up 21% of its $621M portfolio in Q3 2016.
  • Essex Investment Management opened 64 new positions and closed 47 in Q3 2016.
  • Essex Investment Management's portfolio value rose 3.4% quarter-over-quarter to $621M.

Based on Essex Investment Management's 13F filing for Q3 2016, filed 1 Nov 2016.